Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.

Hendrik SeeligerIoannis PoziosGerald AssmannYue ZhaoMario H MüllerThomas KnöselMartin E KreisChristiane J Bruns

Published in: BMC cancer (2018)

In resected PDAC, expression of ER beta seems to correlate with poor prognosis. These data may help to identify patients who may benefit from additional systemic therapy including selective estrogen receptor modulators.

Keyphrases

estrogen receptor
poor prognosis
long non coding rna
lymph node
small molecule
prognostic factors
emergency department
electronic health record
big data
machine learning
mesenchymal stem cells
drug induced